These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7734359)

  • 1. Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin.
    Lindo VS; Kakkar VV; Learmonth M; Melissari E; Zappacosta F; Panico M; Morris HR
    Br J Haematol; 1995 Mar; 89(3):589-601. PubMed ID: 7734359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin.
    Ireland H; Lane DA; Thompson E; Walker ID; Blench I; Morris HR; Freyssinet JM; Grunebaum L; Olds R; Thein SL
    Br J Haematol; 1991 Sep; 79(1):70-4. PubMed ID: 1911389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.
    Raja SM; Chhablani N; Swanson R; Thompson E; Laffan M; Lane DA; Olson ST
    J Biol Chem; 2003 Apr; 278(16):13688-95. PubMed ID: 12591924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation.
    Beauchamp NJ; Pike RN; Daly M; Butler L; Makris M; Dafforn TR; Zhou A; Fitton HL; Preston FE; Peake IR; Carrell RW
    Blood; 1998 Oct; 92(8):2696-706. PubMed ID: 9763552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin Chicago, amino acid substitution of arginine 393 to histidine.
    Erdjument H; Lane DA; Panico M; Di Marzo V; Morris HR; Bauer K; Rosenberg RD
    Thromb Res; 1989 Jun; 54(6):613-9. PubMed ID: 2781509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel amino acid substitution in the reactive site of a congenital variant antithrombin. Antithrombin pescara, ARG393 to pro, caused by a CGT to CCT mutation.
    Lane DA; Erdjument H; Thompson E; Panico M; Di Marzo V; Morris HR; Leone G; De Stefano V; Thein SL
    J Biol Chem; 1989 Jun; 264(17):10200-4. PubMed ID: 2722864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp).
    Bruce D; Perry DJ; Borg JY; Carrell RW; Wardell MR
    J Clin Invest; 1994 Dec; 94(6):2265-74. PubMed ID: 7989582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bothrops jararaca antithrombin: isolation, characterization and comparison with other animal antithrombins.
    de Morais KB; Vieira CO; Hirata IY; Tanaka-Azevedo AM
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Feb; 152(2):171-6. PubMed ID: 19049827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombins Southport (Leu 99 to Val) and Vienna (Gln 118 to Pro): two novel antithrombin variants with abnormal heparin binding.
    Chowdhury V; Mille B; Olds RJ; Lane DA; Watton J; Barrowcliffe TW; Pabinger I; Woodcock BE; Thein SL
    Br J Haematol; 1995 Mar; 89(3):602-9. PubMed ID: 7734360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic effects of antithrombin strand 1C substitution mutations.
    Lane DA; Olds RJ; Conard J; Boisclair M; Bock SC; Hultin M; Abildgaard U; Ireland H; Thompson E; Sas G
    J Clin Invest; 1992 Dec; 90(6):2422-33. PubMed ID: 1469094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational change in antithrombin induced by heparin probed with a monoclonal antibody against the 1C/4B region.
    Dawes J; James K; Lane DA
    Biochemistry; 1994 Apr; 33(14):4375-83. PubMed ID: 7512382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin and its deficiency states.
    Lane DA; Olds RR; Thein SL
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):315-41. PubMed ID: 1643210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate.
    Caso R; Lane DA; Thompson EA; Olds RJ; Thein SL; Panico M; Blench I; Morris HR; Freyssinet JM; Aiach M
    Br J Haematol; 1991 Jan; 77(1):87-92. PubMed ID: 1998601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin III Glasgow: a variant with increased heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis.
    Lane DA; Lowe GD; Flynn A; Thompson E; Ireland H; Erdjument H
    Br J Haematol; 1987 Aug; 66(4):523-7. PubMed ID: 3663509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin Milano, single amino acid substitution at the reactive site, Arg393 to Cys.
    Erdjument H; Lane DA; Ireland H; Di Marzo V; Panico M; Morris HR; Tripodi A; Mannucci PM
    Thromb Haemost; 1988 Dec; 60(3):471-5. PubMed ID: 3238650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chicken antithrombin. Isolation, characterization, and comparison with mammalian antithrombins and chicken ovalbumin.
    Koide T; Ohta Y; Odani S; Ono T
    J Biochem; 1982 Apr; 91(4):1223-9. PubMed ID: 6920385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin and its inherited deficiencies.
    Perry DJ
    Blood Rev; 1994 Mar; 8(1):37-55. PubMed ID: 8205009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleaved antithrombin (ATc): a new marker for thrombin generation and activation of the coagulation system.
    Lindo VS; Kakkar VV; Melissari E
    Br J Haematol; 1995 Jan; 89(1):157-62. PubMed ID: 7833256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobic residues 382-386 of antithrombin III, Ala-Ala-Ala-Ser-Thr, serve as the epitope for an antibody which facilitates hydrolysis of the inhibitor by thrombin.
    Asakura S; Hirata H; Okazaki H; Hashimoto-Gotoh T; Matsuda M
    J Biol Chem; 1990 Mar; 265(9):5135-8. PubMed ID: 1690736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.